Capabilities
Equipped with advanced technologies and automated systems, we operate in GMP-compliant cleanrooms built with energy-efficient and sustainable design principles. Every process is engineered to meet or exceed the most rigorous global safety and quality standards, ensuring consistency, sterility, and excellence at every stage of production.
Manufacturing Facilities
Our state-of-the-art manufacturing facilities are designed to support the safe and scalable production of both vaccines and injectable biologics.
Vaccines
Drug product facilities capable of formulation from 20L to 800L, filling in vials
Our R&D team is currently focused on developing vaccines and biologics for high-priority public health needs, We also collaborate with academic institutions to support advanced training and encourage Ph.D. research among our employees.
Warehouse and distribution centres to handle raw materials, packing materials, consumables, semifinished, finished goods and seed lots &cell banks
Injectables
Sterile Injectable Contract Manufacturing Focused on Insulin & Cartridge-Based Delivery Systems
GMP-Compliant CMO with specialization in insulin and other cartridge-based injectable products
High speed Isolator-based aseptic fill-finish lines with full automation: washing, siliconization, depyrogenation, filling, stoppering, sealing,
Advanced component processors. 100% automated visual inspection lines
Isolator for sterility testing
Tech Transfer Expertise: Formulation adaptation, analytical method transfer, with Dedicated cross-functional project teams that ensure on-time tech transfer and batch execution
Collaborative approach with end-to-end lifecycle support for injectable products
Cold-chain enabled logistics and serialization-ready packaging lines for global compliance
Facility and systems aligned with EU Annex 1, US FDA, WHO GMP, and Schedule M
Fully validated utilities and controlled environments for cleanroom operations
Automation & Pharma 4.0 Integration
Digitally enabled operations with PCS 7, SCADA, EMS, BMS, LIMS, and ERP systems integrated across the facility
Real-time data acquisition, audit trail management, and 21 CFR Part 11 / Annex 11 compliance
Advanced process control systems for ensuring reproducibility, traceability, and continuous improvement
Digital QMS ensuring streamlined deviation, CAPA, change control, and batch release workflows
The QC lab at our injectable facility ensures product quality, safety, and compliance through validated analytical and microbiological testing on raw material, in-process, and finished product testing.
All analytical methods are GMP-compliant and ICH-validated, and aligned with global regulatory standards. With meticulous documentation, regular audits, and continuous training/improvement, the dedicated QC lab plays a vital role in delivering high-quality product, ensuring each dose is safe and effective for public use.
Quality Control Laboratories
Quality Control (QC) laboratories at vaccine plant ensure the safety, efficacy, and quality of the vaccines through stringent control of materials, production processes, and final products.
Our state-of-the-art 50,000 sq.ft. R&D center supports the full spectrum of vaccine development—from pre-clinical studies to product licensure. The facility houses specialized laboratories for molecular biology, immunology, fermentation, purification, cell culture, hybridoma technology, and virus handling, making it ideally equipped for advanced vaccine and biologics research. The R&D center is further supported by a scientific library, lecture hall, centralized monitoring systems, and all essential utilities—creating a fully integrated and modern research environment.
Our R&D team is currently focused on developing vaccines and biologics for high-priority public health needs, We also collaborate with academic institutions to support advanced training and encourage Ph.D. research among our employees.
At GCBC, we believe strongly that collaboration with national and international organizations is key to advancing vaccine innovation and accelerating the path from research to commercialization. These strategic partnerships play a vital role in ensuring that safe, effective, and affordable vaccines reach those who need them most across the globe.
Research & Development
GCBC Vaccines is a research-driven organization that invests into R&D to address critical global health challenges. Backed by strong scientific partnerships and a highly skilled team, our R&D efforts uphold the highest standards of scientific integrity, end-to-end development excellence, and robust pharmacovigilance.
Animal House
GCBC Vaccines also operates a modern Animal House spanning approximately 17,000 sq ft, purpose-built for preclinical vaccine research and fully compliant with Good Laboratory Practices (GLP).
The facility is staffed by trained personnel and designed to meet regulatory standards with controlled housing, observation, and procedural areas—playing a critical role in ensuring vaccine safety and efficacy through in vivo studies.